Skip to main content
. 2018 Jan 15;8:705. doi: 10.1038/s41598-017-17940-8

Figure 3.

Figure 3

Suppression of tumor formation in SKH1 hairless mice treated with liposomes containing UVDE-TAT and UVDE-NLS-TAT. Three representative photographs of mice from each treatment group are shown: control empty liposome formulation Panel (a), liposomes containing UVDE-TAT Panel (b), and liposomes containing UVDE-NLS-TAT Panel (c) at 23 weeks (cumulative dose of 311 kJ/m2).